This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nussbaum, M. S. Articles by Fischer, J. E. Search for Related Content PubMed PubMed Citation Articles by Nussbaum, M. S. Articles by Fischer, J. E. Social Bookmarking                         What's this?

Addition of Lipid to Total Parenteral Nutrition Prevents Hepatic Steatosis in Rats by Lowering the Portal Venous Insulin/Glucagon Ratio

Departments of Surgery, University of Cincinnati Medical Center, The Jewish Hospital of Cincinnati, Cincinnati, Ohio

ShuJun Li, MD

University of California, San Diego

Robert H. Bower, MD, FACS

Departments of Surgery, University of Cincinnati Medical Center

David W. Mcfadden, MD, FACS

Departments of Surgery, University of Cincinnati Medical Center

Rameshwar Dayal, MS

Departments of Surgery, University of Cincinnati Medical Center

Josef E. Fischer, MD, FACS

Departments of Surgery, University of Cincinnati Medical Center

Hepatic steatosis in rats is associated with an infusion of excessive carbohydrate calories. Previous work from this laboratory suggested that this is associated with an elevated portal insulin/glucagon molar ratio (I/G) and is reversed by parenteral glucagon administration. Although hepatic steatosis is not related to essential fatty acid deficiency, addition of lipid to total parenteral nutrition (TPN) has been reported as being protective against the development of hepatic steatosis. Therefore, we propose that lipid may exert its salutary effect via an alteration of the I/G ratio. To test this hypothesis, adult rats (seven per group) received internal jugular catheters: group 1, saline (3 mL/h) plus chow ad libitum; group 2, 25% dextrose base TPN; group 3, 17% dextrose base TPN + 2.5% lipid; group 4, 25% dextrose base TPN + 2.5% lipid. At 7 days, portal and peripheral venous blood was drawn for insulin and glucagon radioimmunoassay and liver function tests; livers were removed for histology and lipid content determination. Panlobular vacuolization, on histology, and lipid content were excessive in group 2, and the portal I/G was increased because of elevated portal insulin. In contrast, portal venous insulin and I/G did not increase, and hepatic steatosis was absent in groups 3 and 4. The results suggest that the addition of lipid to TPN in rats decreases the portal insulin level and lowers the portal I/G, and thereby prevents hepatic steatosis. (Journal of Parenteral and Enteral Nutrition 16:106—109, 1992)

Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 2, 106-109 (1992)
DOI: 10.1177/0148607192016002106


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Poole and K. Froggatt Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional? Palliative Medicine, September 1, 2002; 16(6): 499 - 506. [Abstract] [PDF]

				S. L. Yeh, W. J. Chen, and P. C. Huang Effect of L-Glutamine on Hepatic Lipids at Different Energy Levels in Rats Receiving Total Parenteral Nutrition JPEN J Parenter Enteral Nutr, January 1, 1994; 18(1): 40 - 44. [Abstract] [PDF]